tavaborole nail Kerydin
Selected indexed studies
- Onychomycosis: Treatment and prevention of recurrence. (J Am Acad Dermatol, 2019) [PMID:29959962]
- Onychomycosis: a review. (J Eur Acad Dermatol Venereol, 2020) [PMID:32239567]
- Onychomycosis: Rapid Evidence Review. (Am Fam Physician, 2021) [PMID:34652111]
_Worker-drafted node — pending editorial review._
Connections
tavaborole nail Kerydin is a side effect of
Sources
- Onychomycosis: Treatment and prevention of recurrence. (2019) pubmed
- Updated Perspectives on the Diagnosis and Management of Onychomycosis. (2022) pubmed
- Onychomycosis: Rapid Evidence Review. (2021) pubmed
- Onychomycosis: a review. (2020) pubmed
- Efinaconazole and Tavaborole. (2017) pubmed
- Treatment Options for Onychomycosis: Efficacy, Side Effects, Adherence, Financial Considerations, and Ethics. (2024) pubmed
- In Vitro Nail Penetration of Tavaborole Topical Solution, 5%, Through Nail Polish on Ex Vivo Human Fingernails. (2015) pubmed
- In Vitro Nail Penetration and Antifungal Activity of Tavaborole, a Boron-Based Pharmaceutical. (2015) pubmed
- Tavaborole (AN-2690) for the treatment of onychomycosis of the toenail in adults. (2014) pubmed
- Tavaborole - a treatment for onychomycosis of the toenails. (2016) pubmed